Diagonal Bio Balance Sheet Health
Financial Health criteria checks 3/6
Diagonal Bio has a total shareholder equity of SEK21.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK28.5M and SEK7.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr2.97m |
Equity | kr21.25m |
Total liabilities | kr7.26m |
Total assets | kr28.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DIABIO's short term assets (SEK4.7M) do not cover its short term liabilities (SEK7.3M).
Long Term Liabilities: DIABIO's short term assets (SEK4.7M) exceed its long term liabilities (SEK1,000.0).
Debt to Equity History and Analysis
Debt Level: DIABIO is debt free.
Reducing Debt: DIABIO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DIABIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: DIABIO has less than a year of cash runway if free cash flow continues to grow at historical rates of 5.3% each year.